About Tassa Saldi PhD
Dr. Tassa Saldi is the Co-Founder and Chief Science Officer of TUMI Genomics, a Fort Collins, Colorado-based biotechnology company specializing in advanced pathogen detection and genomic solutions for cannabis cultivation. An accomplished molecular biologist with over 25 years of research experience, Dr. Saldi completed her graduate and post-doctoral studies at the University of Colorado.
At TUMI Genomics, Dr. Saldi developed industry-leading qPCR tests for the detection of Hop Latent Viroid (HLVd) — the molecular cause of "dudding disease" that causes devastating yield loss in cannabis cultivation. Her published research on HLVd tissue-type variability was the first of its kind.
Notable Credentials
- Ph.D. in Molecular Biology, University of Colorado Boulder
- American Cancer Society doctoral fellowship recipient
- 20+ peer-reviewed scientific publications
- Directed COVID-19 testing lab at University of Colorado
- Published pioneering cannabis research on HLVd tissue-type variability
Speaking History
Has appeared at:
MJBizCon 2024 CannaCon
Quick Info
Role
Co-Founder & CSO, TUMI Genomics
Topic Area
Medical & Science
Location
US
Type
Speaker